RT @NoufAhmedAlham2: Biosimilar to biosimilar switching of Infliximab , â¦@RheumNowâ© Kavanaugh #RNL2023 Communicati
Tweet Content
Biosimilar to biosimilar switching of Infliximab , @RheumNow Kavanaugh #RNL2023
Communications is a key always.
Discuss with your patient always, and show them the data. https://t.co/d7Nq6LoJYQ
Show on Archive Page
On
Display in Search Results
On
PDQ
Off